Stockscreener 앱 받기
8.15
0.12%
0.04
Ventyx Biosciences Inc 주식(VTYX)의 최신 뉴스
Ventyx Biosciences, Inc. $VTYX Shares Sold by Redmile Group LLC - MarketBeat
Ongoing Investigation: Ventyx Biosciences, Inc. (VTYX) May Have Misled ShareholdersLevi & Korsinsky Investigates - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc.VTYX - PR Newswire
Ventyx Biosciences, Inc.'s (NASDAQ:VTYX) Large Institutional Owners Must Be Happy as Stock Continues to Impress, up 11% Over the Past Week - 富途牛牛
VTYX Investor Notice: Levi & Korsinsky Investigates Ventyx Biosciences, Inc. for Securities Law Violations - ACCESS Newswire
Ventyx shares drop after pushing back Phase 2 interim results to early 2026 - MSN
Ventyx Biosciences (NASDAQ:VTYX) Trading 12.3% HigherHere's Why - MarketBeat
Affinity Asset Advisors LLC Invests $9.71 Million in Ventyx Biosciences, Inc. $VTYX - MarketBeat
Ventyx Biosciences (NASDAQ:VTYX) Shares Gap DownShould You Sell? - MarketBeat
Ventyx Biosciences, Inc. $VTYX Shares Sold by Sio Capital Management LLC - MarketBeat
Ventyx strengthens advisory board, expands phase 2 pericarditis study By Investing.com - Investing.com Nigeria
Ventyx Biosciences Announces Appointment to Advisory Board - marketscreener.com
Ventyx provides clinical and corporate updates - marketscreener.com
Ventyx Provides Clinical And Corporate Updates - TradingView
Ventyx Biosciences Expands Phase 2 Recurrent Pericarditis Study Into Canada, EU, UK - marketscreener.com
Ventyx stock falls after delaying trial data to Q1 2026 By Investing.com - Investing.com Canada
Ventyx strengthens advisory board, expands phase 2 pericarditis study - Investing.com
Ventyx Provides Clinical and Corporate Updates - The Manila Times
Ventyx adds advisors and delays trial data to Q1 2026 - StreetInsider
Institutional owners may ignore Ventyx Biosciences, Inc.'s (NASDAQ:VTYX) recent US$77m market cap decline as longer-term profits stay in the green - simplywall.st
Ventyx Biosciences, Inc. (NASDAQ:VTYX) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World
Ventyx Biosciences, Inc. (NASDAQ:VTYX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Ventyx Biosciences, Inc. (VTYX) latest stock news and headlines - Yahoo Finance UK
Ventyx Biosciences to Participate in the Piper Sandler 37th Annual Healthcare Conference - The Manila Times
Reviewing Tharimmune (NASDAQ:THAR) and Ventyx Biosciences (NASDAQ:VTYX) - Defense World
Ventyx Biosciences (NASDAQ:VTYX) Reaches New 1-Year HighTime to Buy? - MarketBeat
With 57% ownership, Ventyx Biosciences, Inc. (NASDAQ:VTYX) boasts of strong institutional backing - Yahoo Finance
Catalyst Funds Management Pty Ltd Invests $61,000 in Ventyx Biosciences, Inc. $VTYX - MarketBeat
Ventyx Biosciences (VTYX) Outlook Strengthened by Cost Optimization and Positive Clinical Data - MSN
VTYX Stock Skyrockets 156% in a Month: Here's What You Need to Know - MSN
Ventyx Biosciences (NASDAQ:VTYX) Reaches New 12-Month HighTime to Buy? - MarketBeat
Will Ventyx Biosciences Inc. stock see insider buyingTrade Exit Summary & Weekly High Potential Stock Alerts - newser.com
Does Ventyx Biosciences Inc. stock trade at a discount to peersMarket Volume Report & Weekly High Return Forecasts - newser.com
Is Ventyx Biosciences Inc. stock attractive for growth ETFsJuly 2025 Trade Ideas & Daily Stock Momentum Reports - newser.com
How Ventyx Biosciences Inc. stock reacts to bond yieldsJuly 2025 Analyst Calls & Verified Momentum Stock Ideas - newser.com
Ventyx Biosciences (VTYX) Price Target Increased by 12.94% to 13.99 - MSN
Market reaction to Ventyx Biosciences Inc.’s recent newsGold Moves & Safe Capital Investment Plans - newser.com
Can Ventyx Biosciences Inc. stock double in next 5 years2025 Support & Resistance & Long-Term Growth Stock Strategies - newser.com
[Form 4] Ventyx Biosciences, Inc. Insider Trading Activity - Stock Titan
Is Ventyx Biosciences Inc. still worth holding after the dipStop Loss & Weekly High Potential Stock Alerts - newser.com
Will Ventyx Biosciences Inc. stock recover faster than peersEarnings Growth Report & Pattern Based Trade Signal System - newser.com
How Ventyx Biosciences Inc. stock performs during Fed tightening cycles2025 Pullback Review & AI Driven Stock Reports - newser.com
Ventyx Biosciences at Jefferies Conference: Strategic Focus on NLRP3 Inhibitors - Investing.com Canada
0.56%
1.23%
자본화:
|
볼륨(24시간):